Online program to support families of LGBTQ youth

An Online Family-based Program to Reduce Inequity Among Sexual and Gender Minority Youth of Color (Pilot RCT)

Phase 2 Interventional University of Michigan · NCT06839859

This study is testing an online program to help families of LGBTQ youth understand and support their children better, especially those from diverse backgrounds.

Quick facts

PhasePhase 2
Study typeInterventional
Enrollment180 (estimated)
Ages14 Years and up
SexAll
SponsorUniversity of Michigan Academic / other
Locations1 site (Ann Arbor, Michigan)
Trial IDNCT06839859 on ClinicalTrials.gov

What this trial studies

This pilot intervention aims to help families of sexual and gender minority youth (SGMY) understand and support their children's identities, particularly focusing on those from racial and ethnic minority backgrounds. The Family Acceptance Project utilizes a culture-based family support framework to reduce family rejection and promote acceptance through eight online sessions. Participants include both SGMY aged 14-20 and their caregivers, who will engage in discussions and activities designed to foster supportive family dynamics. The program addresses the mental health challenges faced by SGMY, particularly those experiencing high levels of family rejection.

Who should consider this trial

Good fit: Ideal candidates include sexual and gender minority youth of color aged 14-20 who experience moderate to high levels of family rejection.

Not a fit: Patients who are not experiencing family rejection or those at high risk for suicide may not benefit from this intervention.

Why it matters

Potential benefit: If successful, this program could significantly improve the mental health and well-being of LGBTQ youth by fostering supportive family relationships.

How similar studies have performed: Previous studies have shown that family acceptance interventions can lead to improved outcomes for LGBTQ youth, indicating potential success for this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria (youth):

1. Identify as a sexual/gender minority (including youth questioning their sexual orientation and/or gender identity AND their identity must be known to their participating caregiver).
2. Identify as a person of color/belonging to a minority racial and/or ethnic group.
3. Be between the ages of 14 and 25 years
4. Read and speak English
5. Live in the United States
6. Report consistent access to a phone, tablet, and/or computer with high-speed internet access
7. Report an ability to attend eight, two-hour online sessions at pre-determined times
8. Report moderate to high levels of caregiver/family rejection
9. Not be at high-risk for suicide
10. Not be actively psychotic

Inclusion Criteria (caregivers):

1. Be a caregiver (biological parent, stepparent, grandparent, aunt/uncle, or another adult who provides care) to an SGMY of color between the ages of 14 to 25
2. Be over the age of 18
3. Read and speak English
4. Live in the United States
5. Report consistent access to a phone, tablet, and/or computer with high-speed internet access.
6. Report an ability to attend nine, two-hour online sessions at pre-determined times.
7. Be aware of the SGM youth's minority identity
8. NOT identify as SGM
9. Report spending time with participating youth at least 5 waking hours per week
10. Not be at high-risk for suicide
11. Not be actively psychotic

Where this trial is running

Ann Arbor, Michigan

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions LGBTQRacial DisparitiesFamily RelationshipsMinority StressDepressionAnxietyDrug UseTeen Dating Violence
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.